Par Drugs (India) Analysis
| PAR Stock | 97.85 0.13 0.13% |
Par Drugs And is overvalued with Real Value of 93.94 and Hype Value of 89.33. The main objective of Par Drugs stock analysis is to determine its intrinsic value, which is an estimate of what Par Drugs And is worth, separate from its market price. There are two main types of Par Drugs' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Par Drugs' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Par Drugs' stock to identify patterns and trends that may indicate its future price movements.
The Par Drugs stock is traded in India on National Stock Exchange of India, with the market opening at 09:15:00 and closing at 15:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in India. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Par Drugs' ongoing operational relationships across important fundamental and technical indicators.
Par |
Par Stock Analysis Notes
The company has price-to-book ratio of 1.24. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Par Drugs And recorded earning per share (EPS) of 12.53. The entity last dividend was issued on the 22nd of November 2021. The firm had 2:1 split on the 27th of April 2021. To find out more about Par Drugs And contact Jignesh Savani at 91 26 5299 1022 or learn more at https://www.pardrugs.com.Par Drugs Quarterly Total Revenue |
|
Par Drugs And Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Par Drugs' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Par Drugs And or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Par Drugs And generated a negative expected return over the last 90 days | |
| Par Drugs And has high historical volatility and very poor performance | |
| Par Drugs And is unlikely to experience financial distress in the next 2 years |
Par Drugs Thematic Classifications
In addition to having Par Drugs stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | DrugsDrug manufacturing and delivery |
Par Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.2 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Par Drugs's market, we take the total number of its shares issued and multiply it by Par Drugs's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Par Profitablity
Par Drugs' profitability indicators refer to fundamental financial ratios that showcase Par Drugs' ability to generate income relative to its revenue or operating costs. If, let's say, Par Drugs is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Par Drugs' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Par Drugs' profitability requires more research than a typical breakdown of Par Drugs' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.15 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.02 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.02. Management Efficiency
Par Drugs And has return on total asset (ROA) of 0.1384 % which means that it generated a profit of $0.1384 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2084 %, meaning that it generated $0.2084 on every $100 dollars invested by stockholders. Par Drugs' management efficiency ratios could be used to measure how well Par Drugs manages its routine affairs as well as how well it operates its assets and liabilities. At present, Par Drugs' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 720 M, whereas Non Current Assets Total are forecasted to decline to about 311.6 M.Leadership effectiveness at Par Drugs And is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 23rd of March, Par Drugs holds the Risk Adjusted Performance of (0.31), variance of 10.88, and Coefficient Of Variation of (279.13). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Par Drugs, as well as the relationship between them. Please check Par Drugs And information ratio, and the relationship between the coefficient of variation and value at risk to decide if Par Drugs And is priced some-what accurately, providing market reflects its current price of 97.85 per share.Par Drugs And Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Par Drugs middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Par Drugs And. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Par Drugs Outstanding Bonds
Par Drugs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Par Drugs And uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Par bonds can be classified according to their maturity, which is the date when Par Drugs And has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Par Drugs Predictive Daily Indicators
Par Drugs intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Par Drugs stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Par Drugs Forecast Models
Par Drugs' time-series forecasting models are one of many Par Drugs' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Par Drugs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Par Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Par Drugs prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Par shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Par Drugs. By using and applying Par Stock analysis, traders can create a robust methodology for identifying Par entry and exit points for their positions.
Par Drugs is entity of India. It is traded as Stock on NSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Par Drugs to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Options Analysis Now
Options AnalysisAnalyze and evaluate options and option chains as a potential hedge for your portfolios |
| All Next | Launch Module |
Complementary Tools for Par Stock analysis
When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |